Relaxo Footwears Ltd - 530517 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation of cancellaiton of ESOPs and amendment in RFL Esop Plan 201421-05-2021
Relaxo Footwears Ltd - 530517 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation of cancellaiton of ESOPs and amendment in RFL Esop Plan 2014Relaxo Footwears Ltd - 530517 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation pursant to regulation 30 of SEBI (LODR) Regulations 2015 regarding reappointment of DirectorsRelaxo Footwears Ltd - 530517 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors call (Q4 FY 21 Post Result Conference Call) of Relaxo Footwears Limited will be held on Monday, May 24, 2021, at 04:00 PM (IST).Relaxo Footwears Q4 profit jumps 97.2% to Rs 102.17 crore
The company had posted a profit of Rs 51.80 crore in the January-March quarter of the last financial year.RELAXO FOOTWEARS LTD.-$ - 530517 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on the Audited Financial Results for the Quarter and Year ended on 31st March, 2021RELAXO FOOTWEARS LTD.-$ - 530517 - Corporate Action-Board approves Dividend
Board of Directors have recommended final dividend at the rate of INR 2.50 per equity share (i.e.250%) of face value of INR 1/- each for the approval of members for the year ended March 31, 2021Relaxo Footwears Ltd - 530517 - Corporate Action-Board approves Dividend
Board of Directors have recommended final dividend at the rate of INR 2.50 per equity share (i.e.250%) of face value of INR 1/- each for the approval of members for the year ended March 31, 2021Relaxo Footwears Ltd - 530517 - Board recommends Final Dividend
Relaxo Footwears Ltd has informed BSE that the Board of Directors in their meeting held on May 20, 2021, inter alia, has recommended final dividend at the rate of INR 2.50 per equity share (i.e. 250%) of face value of INR 1/- each for the approval of members for the year ended March 31, 2021.Relaxo Footwears Ltd - 530517 - Audited Financial Result For The Quarter And Year Ended On 31St March, 2021 Along With Auditors Report And Declaration With Respect To Audit Report With Unmodified Opinion
Audited financial Result for the Quarter and year ended on 31st March, 2021 along with Auditors report and declaration with respect to Audit report with unmodified opinion